CLSA PREMIUM (06877) announced the mid-term performance for 2024, with a total operating revenue of ...
According to the announcement, the net profit decreased mainly due to a decrease in revenue and the group's focus on high-gross-margin B2C business, which increased the gross margin of the health business.
The announcement stated that the decrease in net profit was mainly due to a decrease in revenue and the group's focus on high-gross-margin B2C business, which increased the gross margin of the health business.